Long‐term treatment with TGFβ1 impairs mechanotransduction in bovine aortic endothelial cells
Long‐term treatment with TGFβ1 impairs mechanotransduction in bovine aortic endothelial cells
复制标题
DOI:
10.1038/sj.bjp.0707123
复制
发表时间:
2007-02
影响因子:
7.3
通讯作者:
M. Watanabe;M. Oike;Y. Ohta;Y. Ito
中科院分区:
文献类型:
--
作者:
M. Watanabe;M. Oike;Y. Ohta;Y. Ito
Background and purposeVascular endothelial cells play a role in the physiological response to mechanical stress. Transforming growth factor β1(TGFβ1) induces morphological changes in endothelial cells, and this may alter their mechanosensitive responses. The aim of this study was to examine the effects of TGFβ1on hypotonic stress (HTS)‐induced responses in bovine aortic endothelial cells (BAECs).Experimental approachCultured BAECs were treated with 3 ng ml‐1TGFβ1for 24 h (24h‐TGFβ1) or 7 days (7d‐TGFβ1). Cytosolic actin fibres were stained with rhodamine‐phalloidin. Intracellular Ca2+concentration was measured using fura2. Tyrosine phosphorylation and RhoA expression were assessed by Western blotting. Expression of RhoA mRNA was assessed by real‐time PCR.Key resultsBAECs developed pseudopod‐like processes within 24 h and showed a fibroblast‐like appearance after 7 days. HTS induced Ca2+transients via endogenous ATP release in both control and 24h‐TGFβ1BAECs but not in 7d‐TGFβ1BAECs. We have previously shown that HTS‐induced ATP release is mediated by sequential activation of RhoA and tyrosine kinases. The basal amount of membrane‐bound RhoA was significantly lower in 7d‐TGFβ1than in 24h‐TGFβ1or control BAECs. HTS increased the membrane‐bound RhoA to the same fractional level in 24h‐TGFβ1and control BAECs, but its net maximal amount was significantly lower in 7d‐TGFβ1. HTS‐induced downstream signals of RhoA activation, i.e. the tyrosine phosphorylation of FAK and paxillin, were markedly suppressed in 7d‐TGFβ1BAECs.Conclusions and ImplicationsThese results indicate that long‐term treatment with TGFβ1does not impair mechanoreception in BAECs but impairs mechanotransduction by affecting RhoA membrane translocation.British Journal of Pharmacology(2007)150, 424–433. doi:10.1038/sj.bjp.0707123